anidulafungin has been researched along with Infective Endocarditis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corcione, S; D'Avolio, A; De Rosa, FG; Pagani, N; Pasero, D; Sanguinetti, M; Trentalange, A | 1 |
| Gardiner, BJ; Korman, TM; Slavin, MA; Stuart, RL | 1 |
| Carbajal, WH; Lozada, C; Reyes, HA; Valdez, LM | 1 |
| Baietto, L; Centofanti, P; Corcione, S; D'Avolio, A; De Rosa, FG; Di Perri, G; Pasero, D; Raviolo, S; Rinaldi, M | 1 |
4 other study(ies) available for anidulafungin and Infective Endocarditis
| Article | Year |
|---|---|
Acquisition of FKS2 mutation after echinocandin treatment of infective endocarditis by Candida glabrata.
Topics: Aged; Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Candidiasis; Endocarditis; Female; Fungal Proteins; Heart Valve Prosthesis Implantation; Humans; Microbial Sensitivity Tests; Point Mutation; Voriconazole | 2019 |
Hampered by historical paradigms--echinocandins and the treatment of Candida endocarditis.
Topics: Anidulafungin; Antifungal Agents; Candida; Echinocandins; Endocarditis; Fluconazole; Humans; Male; Middle Aged | 2014 |
Successful medical treatment of infective endocarditis caused by Candida parapsilosis in an immunocompromised patient.
Topics: Adult; Anidulafungin; Antifungal Agents; Aorta; Candida; Candidiasis; Cross Infection; Echinocandins; Echocardiography; Endocarditis; Female; Humans; Immunocompromised Host; Ovarian Neoplasms; Voriconazole | 2015 |
Anidulafungin for Candida glabrata infective endocarditis.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Echinocandins; Endocarditis; Female; Hepatitis C; Humans; Liver Cirrhosis; Pancytopenia; Thrombocytopenia; Tricuspid Valve | 2012 |